#United States #FDA Approval #Redmond #Perimetrics #InnerView

FDA Approval for InnerView® System

In a significant advancement for dental diagnostics, Perimetrics, Inc., a leader in dental technology, has announced the FDA’s clearance for their groundbreaking InnerView® System. This marks a pivotal moment as it introduces the first technology capable of measuring both internal and external mobility in dental structures, particularly teeth and implants.

What is the InnerView® System?

The InnerView system utilizes proprietary Quantitative Percussion Diagnostics (QPD™) technology. Unlike traditional methods that depend heavily on visual inspections or tactile assessments, InnerView quantifies internal mobility in teeth—an important factor often associated with underlying structural issues, such as cracks or loose restorations.

According to Robert Hayman, CEO and Chairman of Perimetrics, the technology represents a paradigm shift for how dental professionals can assess and diagnose potential issues ahead of time, thereby improving patient care and outcomes. "Until now, clinicians have relied on subjective feel or surface observation in their attempts to evaluate cracks or failing restorations," he stated during the announcement of the clearance. The ability to objectively measure internal mobility offers dentists new insights into structural changes, which may precede failure.

The Science Behind InnerView®

Backed by a decade of research, supported by 30 clinical studies and 78 global patents, InnerView is the first of its kind to achieve FDA clearance specifically for measuring internal mobility in dental contexts. The technology captures real-time data on how teeth move under stress, presenting metrics that dental professionals can rely on.

While InnerView quantifies mobility, it’s important to note that it does not specifically diagnose or detect cracks or failing restorations. Instead, it provides valuable information regarding their condition, enabling dentists to make better-informed decisions about treatment plans before issues escalate.

Clinical Impact and Future Prospects

This FDA clearance opens up new avenues for clinicians by enhancing their ability to diagnose dental issues early in the process. By detecting subtle changes in mobility, dentists are better equipped to address problems such as loose crowns or structural weaknesses that could lead to more significant challenges in the future.

Moreover, as dental technology continues to advance, systems like InnerView point towards a future of increasingly precise and data-driven dental assessments. These advancements not only elevate clinical standards but also enhance patient trust and confidence in dental care through more predictive and preventative measures.

For those in the dental field, InnerView promises to redefine diagnostic capabilities. Clinicians looking to incorporate this revolutionary technology into their practice can find more information by visiting Perimetrics' website or contacting the company directly.

Conclusion

The InnerView® System by Perimetrics is more than just a technological advancement; it signifies a leap toward objective diagnostics in dentistry. This innovation marks a transformative moment, potentially preventing costly and painful dental problems through early detection and intervention, ultimately leading to healthier patients and more successful practices.